Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

19.040
+0.0800.42%
Volume:3.68M
Turnover:69.90M
Market Cap:21.67B
PE:-15.14
High:19.340
Open:19.000
Low:18.870
Close:18.960
52wk High:27.280
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:0.53
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.257
ROE:-26.91%
ROA:-14.75%
PB:4.55
PE(LYR):-15.14
PS:6.14

Loading ...

Stock Track | Zai Lab Soars 5.05% Intraday on Clinical Collaboration with Boehringer Ingelheim for Novel Cancer Therapy

Stock Track
·
Apr 16

Zai Lab Shares Climb Over 4% on Partnership with Boehringer Ingelheim for Novel Dual DLL3-Targeting Combination Therapy

Stock News
·
Apr 16

Asian Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live
·
Apr 15

Zai Lab, Boehringer Ingelheim team up on DLL3 combo trial in lung cancer

Reuters
·
Apr 15

Boehringer Ingelheim and Zai Lab Announce Collaboration on Dll3‑Targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

THOMSON REUTERS
·
Apr 15

Zai Lab Ltd: Under Agreement, Co to Supply Dll3‑Targeting ADC for Study, Boehringer to Sponsor & Oversee Day‑to‑Day Clinical Operations

THOMSON REUTERS
·
Apr 15

Zai Lab Shares Climb Over 3% Following Global Clinical Partnership with Amgen for Zoci Candidate

Stock News
·
Apr 14

Zai Lab Boosts Issued Share Base by 6.00 Million in March; Public Float Remains Above 25%

Bulletin Express
·
Apr 08

Zai Lab Grants Stock Options, Restricted Share Units, and Performance Share Units

Stock News
·
Apr 02

Zai Lab grants equity awards covering 9 million shares under 2024 incentive plan

Reuters
·
Apr 02

Zai Lab Rises Nearly 5% in Morning Session Following Global Clinical Research Collaboration with Amgen

Deep News
·
Apr 02

Stock Track | Zai Lab Soars 5.94% Intraday on Clinical Partnership with Amgen for Lung Cancer Treatment

Stock Track
·
Apr 02

Zai Lab Shares Climb Over 4% Following Global Clinical Partnership with Amgen for Small Cell Lung Cancer Treatment

Stock News
·
Apr 02

Asian Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

MT Newswires Live
·
Apr 01

BRIEF-Zai Lab Announces Global Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Dll3 Adc, Zocilurtatug Pelitecan, In Combination With A Bispecific T-Cell Engager Therapy

Reuters
·
Apr 01

Zai Lab, Amgen partner on global trial of DLL3 ADC with Imdelltra in SCLC

Reuters
·
Apr 01

Zai Lab Ltd - Announces Global Clinical Trial Collaboration With Amgen for Es-Sclc

THOMSON REUTERS
·
Apr 01

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel Dll3 ADC, Zocilurtatug Pelitecan, in Combination With a Bispecific T-Cell Engager Therapy

THOMSON REUTERS
·
Apr 01

Nanjing Leads Biolabs non-executive director Ni Jia resigns; Wu Fenglan nominated as non-executive director

Reuters
·
Mar 27

Zai Lab files next day disclosure return with Hong Kong Stock Exchange; share capital rises by 6,000,000 shares at HKD 0

Reuters
·
Mar 27